A portrait of clinical and epidemiological aspects of cervical cancer in Latin America is required to understand the high frequency of cervical cancer despite the existence of effective preventive tools. A better understanding of the current situation of this scenario will provide a valuable groundwork for the development of national and cooperative programs to improve cervical cancer prevention and treatment.

Inclusion Criteria:

• Women > 18 years.
• Histologically proven cervical carcinoma
• Diagnosis of carcinoma of the cervix since January 2018 or newly diagnosis or recurrent disease during the period of study recruitment.
• Any histology of cervical cancer at time of diagnosis.
• FIGO stage IB2-IVA
• Have available and adequate medical records for data collection
• Accept to participate in the project and sign the informed consent (if applicable)

Exclusion Criteria:

• FIGO stage I and IB1
• Non-invasive cervical cancer
• Synchronous tumor or second primary tumor in the last five years (exception for thyroid cancer or skin cancer non melanoma)

Data from approximately 482 patients are planned to be collected in 7 (seven) countries in Latin America. Enrollment period for data collection is planned to be 18 months and follow-up data will be recorded for 5 years. Patients will receive treatment and clinical assessments for cervical cancer as determined by their treating physician, according to the standard of care and routine clinical practice at each site.